Form D · Pharmaceuticals

Novadiol Australia, Inc.

Shawnee, KS · CIK 0001578175

Offering snapshot reported Jul 3, 2014 · SEC filing

Reported sold
$1.1M
Offering amount: $2M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 31, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$548K$1.1MJun 4, 2013: $150,000.00Jun 4, 2013Jun 5, 2013: $150,000.00Jul 3, 2014: $1,095,000.00Jul 3, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$150,000 → $1,095,000
  • Reported investors1 → 10

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 3, 2014Amendment$1,095,000$945,000vs Jun 5, 201310SEC filing
Jun 5, 2013Amendment$150,000$0vs Jun 4, 20131SEC filing
Jun 4, 2013Initial$150,000No comparison1SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-197453

Source: Form D, filed Jul 3, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
G. P. Georges Director, Executive
G. P. Georges Director, Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
6425 Nieman
Shawnee, KS, 66203